Dementia and cognitive impairment

Computerised cognitive training for preventing dementia in people with mild cognitive impairment

Abstract Background The number of people living with dementia is increasing rapidly. Clinical dementia does not develop suddenly, but rather is preceded by a period of cognitive decline beyond normal age‐related change. People at this intermediate stage between normal cognitive function and clinical dementia are often described as having mild cognitive impairment (MCI). Considerable research […]

Share

De‐escalation techniques for managing non‐psychosis induced aggression in adults

Abstract Background Aggression occurs frequently within health and social care settings. It can result in injury to patients and staff and can adversely affect staff performance and well‐being. De‐escalation is a widely used and recommended intervention for managing aggression, but the efficacy of the intervention as a whole and the specific techniques that comprise it […]

Share

Modifying the consistency of food and fluids for swallowing difficulties in dementia

Abstract Background People with dementia can have feeding and swallowing difficulties(dysphagia). Modification of the consistency of food or fluids, or both, is a common management strategy. However, diet modification can affect quality of life and may lead to dehydration and malnutrition. Evidence on the benefits and risks of modifyingfood and fluids is mandatory to improve […]

Share

Art therapy for people with dementia

Abstract Background Art therapy is defined by the British Association of Art Therapists as: “a form of psychotherapy that uses art media as its primary mode of communication. Clients who are referred to an art therapist need not have experience or skill in art. The art therapist is not primarily concerned with making an aesthetic […]

Share

Mindfulness-based stress reduction for family carers of people with dementia

Abstract Background Caring for people with dementia is highly challenging, and family carers are recognised as being at increased risk of physical and mental ill‐health. Most current interventions have limited success in reducing stress among carers of people with dementia. Mindfulness‐based stress reduction (MBSR) draws on a range of practices and may be a promising […]

Share

Pharmacological interventions for apathy in Alzheimer’s disease

Abstract Background Despite the high prevalence of apathy in Alzheimer’s disease (AD), and its harmful effects, there are currently no therapies proven to treat this symptom. Recently, a number of pharmacological therapies have been investigated as potential treatments for apathy in AD. Objectives Objective 1: To assess the safety and efficacy of pharmacotherapies for the […]

Share

Personally tailored activities for improving psychosocial outcomes for people with dementia in long-term care

Abstract Background People with dementia who are being cared for in long-term care settings are often not engaged in meaningful activities. Offering them activities which are tailored to their individual interests and preferences might improve their quality of life and reduce challenging behaviour. Objectives ∙ To assess the effects of personally tailored activities on psychosocial […]

Share

18F PET with florbetapir for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)

Abstract Background 18F-florbetapir uptake by brain tissue measured by positron emission tomography (PET) is accepted by regulatory agencies like the Food and Drug Administration (FDA) and the European Medicine Agencies (EMA) for assessing amyloid load in people with dementia. Its added value is mainly demonstrated by excluding Alzheimer’s pathology in an established dementia diagnosis. However, […]

Share

18F PET with florbetaben for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)

Abstract Background 18F-florbetaben uptake by brain tissue, measured by positron emission tomography (PET), is accepted by regulatory agencies like the Food and Drug Administration (FDA) and the European Medicine Agencies (EMA) for assessing amyloid load in people with dementia. Its added value is mainly demonstrated by excluding Alzheimer’s pathology in an established dementia diagnosis. However, […]

Share

Music-based therapeutic interventions for people with dementia

Abstract Background Dementia is a clinical syndrome with a number of different causes which is characterised by deterioration in cognitive, behavioural, social and emotional functions. Pharmacological interventions are available but have limited effect to treat many of the syndrome’s features. Less research has been directed towards non-pharmacological treatments. In this review, we examined the evidence […]

Share
  • The review abstracts published on this site are the property of John Wiley & Sons, Ltd., and of the Cochrane Review Groups that have produced the reviews.
Share
Share